secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2022-04-27T23:59:59+00:00
Accession:  0001558370-22-006121
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne adopts Fourth Amended and Restated Bylaws with new shareholder meeting procedures
--------------------------------------------------------------------------------

- Uncontested director elections changed to majority of votes cast, consistent with amended articles.
- Shareholder proposal and nomination notice window moved to 90-120 days before anniversary of prior annual meeting.
- Shareholders soliciting support for director nominees must represent intent to seek 67% voting power and provide evidence.
- Lead Director position established; Chairman and Lead Director are non-officer roles.
- Board may hold special meetings on less than 24 hours' notice if deemed necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837022006121/0001558370-22-006121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837022006121/tmb-20220426x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-006121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer